Get the Stockscreener App
5.52
1.95%
-0.11
Orchestra Biomed Holdings Inc stock is traded at $5.52, with a volume of 4,739.
It is down -1.95% in the last 24 hours and down -1.78% over the past month.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$5.63
Open:
$5.64
24h Volume:
4,739
Relative Volume:
0.05
Market Cap:
$212.95M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-3.68
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
+5.34%
1M Performance:
-1.78%
6M Performance:
-5.32%
1Y Performance:
-18.70%
1-Day Range:
$5.50
$5.67
1-Week Range:
$5.00
$6.16
52-Week Range:
$3.96
$8.8699
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
5.50 | 212.95M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.76 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.62 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
651.19 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.15 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.44 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN
Orchestra BioMed Announces Appointment of Former Medtronic - GlobeNewswire
Orchestra BioMed Appoints New Director Amid Board Changes - TipRanks
Medtronic M&A Veteran Who Led $60B+ in Deals Joins Orchestra BioMed Board - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Barclays PLC Increases Stock Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
When (OBIO) Moves Investors should Listen - Stock Traders Daily
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Jane Street Group LLC - Defense World
(OBIO) Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Purchases 11,002 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Barclays PLC Increases Stake in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
US Penny Stocks Spotlight: AC Immune And Two Others To Consider - Simply Wall St
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated by Analysts at Barclays - Defense World
Barclays Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Overweight Recommendation - MSN
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead
Orchestra BioMed Up 49% After Barclays Starts Coverage With $16 Target - MarketWatch
Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn
Orchestra BioMed (NASDAQ:OBIO) Now Covered by Barclays - MarketBeat
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Orchestra Orchestra BioMed stock rated Overweight on novel medtech model By Investing.com - Investing.com Nigeria
State Street Corp Has $2.21 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra Biomed CEO David Hochman buys $18,640 in common stock By Investing.com - Investing.com Australia
Orchestra Biomed CEO David Hochman buys $18,640 in common stock - Investing.com India
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Purchases 4,000 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds - Yahoo Finance
Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com
Orchestra Biomed CEO David Hochman buys $24,550 in stock By Investing.com - Investing.com Canada
Orchestra Biomed CEO David Hochman buys $24,550 in stock - Investing.com India
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Acquires 5,000 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Here's Why We're Watching Orchestra BioMed Holdings' (NASDAQ:OBIO) Cash Burn Situation - Simply Wall St
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock Position Lowered by The Manufacturers Life Insurance Company - Defense World
(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting - GlobeNewswire
Orchestra BioMed to Present Breakthrough AVIM Therapy Data for Hypertension Treatment at ICI 2024 - StockTitan
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN
RTW Investments LP Has $42.18 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Orchestra BioMed to Present at Piper Sandler Healthcare Conference | OBIO Stock News - StockTitan
Orchestra BioMed to Present at Jefferies London Healthcare Conference - MSN
HC Wainwright Has Positive Estimate for OBIO FY2024 Earnings - MarketBeat
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Research Analysts Offer Predictions for OBIO FY2024 Earnings - Defense World
What is Chardan Capital's Forecast for OBIO FY2024 Earnings? - MarketBeat
B. Riley Lifts Earnings Estimates for Orchestra BioMed - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orchestra Biomed Holdings Inc Stock (OBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hochman David P | See Remarks |
Dec 23 '24 |
Buy |
4.66 |
4,000 |
18,640 |
579,498 |
| Taylor Andrew Lawrence | Chief Financial Officer |
Dec 19 '24 |
Buy |
4.83 |
1,000 |
4,830 |
344,960 |
| Hochman David P | See Remarks |
Dec 18 '24 |
Buy |
4.91 |
5,000 |
24,550 |
575,498 |
| Hochman David P | See Remarks |
Sep 25 '24 |
Buy |
4.75 |
7,500 |
35,630 |
335,002 |
| Hochman David P | See Remarks |
Sep 24 '24 |
Buy |
4.91 |
2,500 |
12,275 |
570,498 |
| Sherman Darren | See Remarks |
Sep 09 '24 |
Sale |
5.48 |
6,804 |
37,286 |
772,691 |
| Sherman Darren | See Remarks |
Sep 10 '24 |
Sale |
5.31 |
6,904 |
36,660 |
765,787 |
| Fain Eric S | Director |
Sep 06 '24 |
Sale |
5.64 |
2,000 |
11,280 |
44,810 |
| Fain Eric S | Director |
Sep 09 '24 |
Sale |
5.43 |
1,800 |
9,774 |
43,010 |
| Fain Eric S | Director |
Sep 10 '24 |
Sale |
5.34 |
1,800 |
9,612 |
41,210 |
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):